Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
about
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early deathTheiler's virus infection: a model for multiple sclerosisAnergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivoRegulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytesA critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cellsAntigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitisRegulating the immune system: the induction of regulatory T cells in the peripheryMechanism of oral tolerance induction to therapeutic proteinsMechanisms of Oral ToleranceTargeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory diseaseTolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cellsTargeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-betaTGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytesTGF-β signaling in T cells: roles in lymphoid and epithelial neoplasiaInduction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease.Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injuryStreptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking.Immunomodulators in human seminal plasma: a vital protection for spermatozoa in the presence of infection?Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.Strategies of mucosal immunotherapy for allergic diseasesAbrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets.Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cellsCD27-CD70 interactions regulate B-cell activation by T cellsCD8(+) T cell subsets and chronic obstructive pulmonary disease.Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats.Oral tolerance in the absence of naturally occurring TregsThe nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routesCD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in miceThe opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease.Immunological tolerance to inhaled antigen.Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity.Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitisSelective immunointervention in autoimmune diseases: lessons from multiple sclerosis.In vivo instruction of suppressor commitment in naive T cellsIn vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.
P2860
Q24563654-E096E1CB-60F8-4341-861E-0699A8E099C8Q24629115-64EA2677-D472-4931-A547-14B8083D7F03Q24671959-3A32C7EA-5FFE-4148-B2F4-0BC1EB57F61CQ24676786-33826A52-5D3C-45E9-97E0-27211EDFB65DQ24678065-357217C3-F4CF-4D51-BB9D-2DF32BC6B6A0Q24791647-FD51500A-8F64-4B99-AB99-11B7741D3B1AQ24796969-F81BBBB5-3D8F-4CCB-9821-042059EE2CE7Q26866369-28BDFA70-C163-4A02-A193-C71955CA0EBBQ28082715-229CF6B9-5619-4B3B-87BD-51CE4DB736ECQ28202655-A6151C44-9D4C-4596-9304-6CA3954BD5B1Q28565650-E10DD173-2B8C-43F3-9B67-5DBC98AAEC16Q28594801-D874E93C-29ED-4F98-9D7E-FDAD78E69E0AQ28594881-87872834-39AA-49F8-A28C-3BFBBB8C9690Q29036999-76EB6870-3387-4C9E-95F9-63E62D8AF1A2Q30480826-02B14FD0-72DF-4C17-A6BE-571F43CE87D7Q33195470-062BA4FB-4E38-4C46-B289-C3B75A49DE6EQ33506614-B79DA74C-B946-46EF-BFF0-B897B08127F3Q33539336-30E29A11-E8C5-4EB0-A4A8-873D7118063EQ33546205-F6391215-9060-4753-99C1-C570813344EDQ33577679-377D42A1-49BE-4659-A8CC-28F198BAAAE6Q33597356-4997D902-75B4-4AB8-B87F-113BCD80FC0DQ33611559-351E63D1-F7CF-4B97-AA47-EE717EE71711Q33624770-F84574FF-3FF5-4F16-8889-DF6BFC502515Q33768464-B067CDAD-EA4D-4E80-9284-67C0E5994C1AQ33771444-E3963BB9-BDEC-40EC-80FE-34A43B2480BBQ33783833-BAB81431-4B71-4BF3-BE76-F0E09277EF94Q33840440-7C91626E-E47B-4212-B955-07DA42CC32C1Q33947964-FD4B6C3A-D891-4436-8B71-BF45C0C6F6D3Q34025491-06005BE4-2B84-48FF-B808-0F827DAECA29Q34027844-097E462E-2DEC-448B-A4AB-6A693CBC9445Q34058676-0AA7EB55-1D3D-4638-AA9A-2FF6979F8D74Q34106906-FF65EC68-EF1A-4322-98DA-45FF21906E1FQ34190602-3C30236B-A7D1-4195-8EB1-ED92E100EAD9Q34191045-F2F8EEFA-31BA-4617-ADF3-B8F3129AC206Q34201095-39D0B305-5F4F-443E-8EF9-C8AF9457E138Q34223823-F474E1B8-008B-4E35-B3F0-5ACB94C947E3Q34248488-BE7BD2DE-86C2-4928-B4B0-E710BEED30E6Q34307160-D842AEFC-083E-4BC3-8978-05AB4C4EAE13Q34548023-00A9C31B-7E05-41A2-A552-67CE0C2D193DQ34999663-2C78B985-3545-4BE8-BD55-ECE8908D82A2
P2860
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Suppressor T cells generated b ...... er antigen-specific triggering
@ast
Suppressor T cells generated b ...... er antigen-specific triggering
@en
type
label
Suppressor T cells generated b ...... er antigen-specific triggering
@ast
Suppressor T cells generated b ...... er antigen-specific triggering
@en
prefLabel
Suppressor T cells generated b ...... er antigen-specific triggering
@ast
Suppressor T cells generated b ...... er antigen-specific triggering
@en
P2093
P2860
P356
P1476
Suppressor T cells generated b ...... er antigen-specific triggering
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.1.421
P407
P577
1992-01-01T00:00:00Z